PURE Bioscience Statistics
Total Valuation
PURE Bioscience has a market cap or net worth of 6.80 million. The enterprise value is 11.16 million.
| Market Cap | 6.80M |
| Enterprise Value | 11.16M |
Important Dates
The last earnings date was Friday, June 13, 2025.
| Earnings Date | Jun 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PURE Bioscience has 111.89 million shares outstanding. The number of shares has increased by 0.07% in one year.
| Current Share Class | 111.89M |
| Shares Outstanding | 111.89M |
| Shares Change (YoY) | +0.07% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 41.25% |
| Owned by Institutions (%) | n/a |
| Float | 65.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.56 |
| PB Ratio | -1.41 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.95 |
| EV / Sales | 5.84 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.08
| Current Ratio | 1.08 |
| Quick Ratio | 0.85 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.83 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -162.81% |
| Return on Invested Capital (ROIC) | -949.48% |
| Return on Capital Employed (ROCE) | -3,029.41% |
| Revenue Per Employee | 159,333 |
| Profits Per Employee | -235,250 |
| Employee Count | 12 |
| Asset Turnover | 1.93 |
| Inventory Turnover | 7.82 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.63% in the last 52 weeks. The beta is 0.30, so PURE Bioscience's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | -5.63% |
| 50-Day Moving Average | 0.08 |
| 200-Day Moving Average | 0.08 |
| Relative Strength Index (RSI) | 35.91 |
| Average Volume (20 Days) | 33,283 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.35 |
Income Statement
In the last 12 months, PURE Bioscience had revenue of 1.91 million and -2.82 million in losses. Loss per share was -0.03.
| Revenue | 1.91M |
| Gross Profit | 1.11M |
| Operating Income | -2.58M |
| Pretax Income | -2.82M |
| Net Income | -2.82M |
| EBITDA | -2.54M |
| EBIT | -2.58M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 540,000 in cash and 4.90 million in debt, giving a net cash position of -4.36 million or -0.04 per share.
| Cash & Cash Equivalents | 540,000 |
| Total Debt | 4.90M |
| Net Cash | -4.36M |
| Net Cash Per Share | -0.04 |
| Equity (Book Value) | -4.81M |
| Book Value Per Share | -0.04 |
| Working Capital | 74,000 |
Cash Flow
| Operating Cash Flow | -2.15M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 58.05%, with operating and profit margins of -134.68% and -147.65%.
| Gross Margin | 58.05% |
| Operating Margin | -134.68% |
| Pretax Margin | -147.65% |
| Profit Margin | -147.65% |
| EBITDA Margin | -132.58% |
| EBIT Margin | -134.68% |
| FCF Margin | n/a |
Dividends & Yields
PURE Bioscience does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.07% |
| Shareholder Yield | n/a |
| Earnings Yield | -41.50% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 15, 2012. It was a reverse split with a ratio of 0.125.
| Last Split Date | Aug 15, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.125 |
Scores
PURE Bioscience has an Altman Z-Score of -188.94 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -188.94 |
| Piotroski F-Score | 3 |